Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitro

Environmental Toxicology and Pharmacology

Volumn 29, Issue 3, 2010, Pages 229-234

  Zhou, Yongqiang ^a   Li, Weize ^a   Chen, Lvyi ^a   Ma, Shuwei ^a   Ping, Li ^a   Yang Zhonglin, Z ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Absorption; Akebia saponin D; Borneol; Everted gut sac model; Intestinal perfusion method; Probenecid

Indexed keywords

BORNEOL; BREAST CANCER RESISTANCE PROTEIN; DIMETHYL SULFOXIDE; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PANTOPRAZOLE; POLYSORBATE 80; PROBENECID; SAPONIN; TRITERPENOID; VERAPAMIL;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIPSACACEAE; DRUG ABSORPTION; DRUG ADSORPTION; DRUG ISOLATION; DRUG POTENTIATION; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSPORT; EXPERIMENTAL MODEL; IN VITRO STUDY; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTESTINE PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RHIZOME;

AKEBIA; DIPSACUS;

EID: 77951975329     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2010.01.004     Document Type: Article

References (20)

1. Balimane P.V., Chong S., Morrison R.A. Current methodologies used for evaluation of intestinal permeability and absorption. J. Pharmacol. Toxicol. Meth. 2000, 44:301-312.
2. Breedveld P., Beijnen J.H., Schellens J.H.M. Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. Trends Pharmacol. Sci. 2006, 27:17-24.
3. Bulmer A.C., Blanchfield J.T., Coombes J.S., Toth I. In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. Bioorgan. Med. Chem. 2008, 16:3616-3625.
4. Cole S.P.C., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., Stewart A.J., Kurz E.U., Duncan A.M.V., Deeley R.G. Overexpression of a transporter gene in a multidrug-resistant human lung-cancer cell-line. Science 1992, 258:1650-1654.
5. Gao Y., He L., Katsumi H., Sakane T., Fujita T., Yamamoto A. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Int. J. Pharm. 2008, 354:126-134.
6. Horvathova E., Slamenova D., Marsalkova L., Sramkova M., Wsolova L. Effects of borneol on the level of DNA damage induced in primary rat hepatocytes and testicular cells by hydrogen peroxide. Food Chem. Toxicol. 2009, 47:1318-1323.
7. Hung T.M., Na M.K., Thuong P.T., Su N.D., Sok D.E., Song K.S., Seong Y.H., Bae K.H. Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J. Ethnopharmacol. 2006, 108:188-192.
8. Jain R., Duvvuri S., Kansara V., Mandava N.K., Mitra A.K. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats. Int. J. Pharm. 2007, 336:233-240.
9. Jain R., Agarwal S., Mandave N.K., Sheng Y., Mitra A.K. Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux. Int. J. Pharm. 2008, 362:44-51.
10. Kim H.S., Min Y.D., Choi C.H. Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid. Biochem. Biophys. Res. Co. 2001, 283:64-71.
11. Kouno I., Tsuboi A., Nanri M., Kawano N. Acylated triterpene glycoside from roots of Dipsacus asper. Phytochemistry 1990, 29:338-339.
12. Leslie E.M., Deeley R.G., Cole S.P.C. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharm. 2005, 204:216-237.
13. Li H.L., Zhao X.B., Ma Y.K., Zhai G.X., Li L.B., Lou H.X. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J. Control. Rel. 2009, 133:238-244.
14. Lv H., Wang G., Wu X., Xie L., Huang C., Li H., Liang Y., Hao H., Sun J. Transport characteristics of ginkgolide B by Caco-2 cells and examination of ginkgolide B oral absorption potential using rat in situ intestinal loop method. Int. J. Pharm. 2008, 351:31-35.
15. Sababi M., Borga O., Bengtsson U.H. The role of P-glycoprotein in limiting intestinal region absorption of digoxin in rats. Eur. J. Pharm. Sci. 2001, 14:21-27.
16. Saitoh H., Aungst B.J. Possible involvement of multiple P-glycoprotein-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 1995, 12:1304-1310.
17. Sharma P., Chawla H.P.S., Panchagnula R. LC determination of cephalosporins in in vitro rat intestinal sac absorption model. J. Pharmaceut. Biomed. 2002, 27:39-50.
18. Wang L., Jiang X., Xu W., Li C. Complexation of tanshinone IIA with 2-hydroxypropyl-β-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats. Int. J. Pharm. 2007, 341:58-67.
19. Wu S.R., Cheng G., Wang L., Zou M.J., Gui F.D. Effects of borneol on the absorption kinetics of the rifampicin in rat's intestines. J. Shenyang Pharm. Univ. 2003, 20:245-248.
20. Xiao Y.Y., Ping Q.N., Chen Z.P. The enhancing effect of synthetical borneol on the absorption of tetramethylpyrazine phosphate in mouse. Int. J. Pharm. 2007, 337:74-79.